Clinical Trial Update: Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing muraglitazar to pioglitazone in adults with Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Muraglitazar (muraglitazar)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED